Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q2 2018 13F Holders as of 30 Jun 2018
- Type / Class
- Equity / Common Shares, No Par Value
- Shares outstanding
- 28,495,649
- Total 13F shares
- 8,778,305
- Share change
- +137,623
- Total reported value
- $22,385,400
- Price per share
- $2.55
- Number of holders
- 24
- Value change
- +$392,217
- Number of buys
- 8
- Number of sells
- 19
Quarterly Holders Quick Answers
What is CUSIP 68235C107?
CUSIP 68235C107 identifies OCX - Oncocyte Corporation - Common Shares, No Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 68235C107:
Top shareholders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
|
Company |
27%
|
7,564,934
|
$15,886,000 | — | 31 Mar 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
355,533
|
$747,000 | — | 31 Mar 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.72%
|
205,187
|
$431,000 | — | 31 Mar 2018 | |
| Artal Group S.A. |
13F
|
Company |
0.53%
|
150,000
|
$315,000 | — | 31 Mar 2018 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.4%
|
115,000
|
$242,000 | — | 31 Mar 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.15%
|
44,064
|
$92,000 | — | 31 Mar 2018 | |
| Destination Wealth Management |
13F
|
Company |
0.1%
|
29,656
|
$62,000 | — | 31 Mar 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.1%
|
29,217
|
$61,000 | — | 31 Mar 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
23,855
|
$50,000 | — | 31 Mar 2018 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
18,211
|
$39,000 | — | 31 Mar 2018 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
17,771
|
$37,000 | — | 31 Mar 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.06%
|
16,082
|
$34,000 | — | 31 Mar 2018 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.06%
|
15,700
|
$33,000 | — | 31 Mar 2018 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
0.05%
|
13,042
|
$27,000 | — | 31 Mar 2018 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
6,400
|
$13,000 | — | 31 Mar 2018 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
5,873
|
$12,000 | — | 31 Mar 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
5,054
|
$10,000 | — | 31 Mar 2018 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.02%
|
4,589
|
$10,000 | — | 31 Mar 2018 | |
| STRS OHIO |
13F
|
Company |
0.02%
|
4,600
|
$9,000 | — | 31 Mar 2018 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
2,456
|
$5,000 | — | 31 Mar 2018 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
1,348
|
$3,000 | — | 31 Mar 2018 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,234
|
$3,000 | — | 31 Mar 2018 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
796
|
$2,000 | — | 31 Mar 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
764
|
$2,000 | — | 31 Mar 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
538
|
$2,000 | — | 31 Mar 2018 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
833
|
$1,749 | — | 31 Mar 2018 | |
| Carroll Financial Associates, Inc. |
13F
|
Company |
0%
|
850
|
$1,000 | — | 31 Mar 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
607
|
$1,000 | — | 31 Mar 2018 | |
| IHT Wealth Management, LLC |
13F
|
Company |
0%
|
563
|
$1,000 | — | 31 Mar 2018 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
500
|
$1,000 | — | 31 Mar 2018 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
384
|
$1,000 | — | 31 Mar 2018 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
343
|
$1,000 | — | 31 Mar 2018 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
316
|
$1,000 | — | 31 Mar 2018 |
Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q2 2018
As of 30 Jun 2018,
Oncocyte Corporation - Common Shares, No Par Value (OCX) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,778,305 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT INC, Artal Group S.A., MILLENNIUM MANAGEMENT LLC, BlackRock Inc., ELEMENT CAPITAL MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and Williams Jones & Associates LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2018 vs Q1 2018 Across Filers
Q1 2018 holders
27
Q2 2018 holders
24
Holder diff
-3
| Investor | Q1 2018 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q1 2018 Value $ | Q2 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.